December 28, 2006
A whistle-blower law suit claims that the state of Texas was duped by Johnson & Johnson into spending millions of dollars on the antipsychotic drug Risperdal. The suit, which has been joined by the Texas attorney general’s office, alleges that the company and its subsidiaries misled state officials about the benefits of the drug and promoted it for uses that had not been approved by the FDA.
Additional details are available in the December 20, 2006 issue of the Dallas-Ft Worth Star-Telegram.